TAUOPATHIES

Clinical trials for TAUOPATHIES explained in plain language.

Never miss a new study

Get alerted when new TAUOPATHIES trials appear

Sign up with your email to follow new studies for TAUOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Completed 2 Terminated 1

Promising Alzheimer's drug donanemab enters final phase trial

Disease control Ongoing

This study tests whether donanemab can slow memory and thinking decline in people with early Alzheimer's disease. About 1,500 participants with mild symptoms and brain amyloid plaques will receive the drug or a placebo for up to 93 weeks. The main goal is to see if donanemab help…

Matched conditions: TAUOPATHIES

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated May 26, 2026 08:27 UTC

TAUOPATHIES

Get alerted when new TAUOPATHIES trials appear

Promising Alzheimer's drug donanemab enters final phase trial